Outcome of Patients With Early-Stage Breast Cancer Treated With Doxorubicin-Based Adjuvant Chemotherapy As a Function of HER2 and TOP2A Status

PURPOSE: Amplification and deletion of the TOP2A gene have been reported as positive predictive markers of response to anthracycline-based therapy. We determined the status of the HER2 and TOP2A genes in a large cohort of breast cancer patients treated with adjuvant doxorubicin (A) and cyclophospham...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Tubbs, Raymond, Barlow, William E., Budd, G. Thomas, Swain, Eric, Porter, Peggy, Gown, Allen, Yeh, I-Ten, Sledge, George, Shapiro, Charles, Ingle, James, Haskell, Charles, Albain, Kathy S., Livingston, Robert, Hayes, Daniel F.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Clinical Oncology 2009
Θέματα:
Original Reports
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2734394/
https://ncbi.nlm.nih.gov/pubmed/19620488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.20.1566
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια